Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox (ONTAK), and Pentostatin in Combination With Corticosteroids (BMT CTN #0302)
收藏DataCite Commons2026-02-05 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00000064/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The study is a randomized Phase II, four arm treatment trial. The primary purpose of the study is to define new agents with promising activity against acute graft-versus-host disease (GVHD) suitable for testing against corticosteroids alone in a subsequent Phase III trial.
提供机构：
Vivli
创建时间：
2018-10-27
